Supervised disulfiram treatment in a telemedicine setting - What impact does the loss of personal doctor-patient interaction have on the probability of relapse and patient compliance?
Recruiting
- Conditions
- F10Mental and behavioural disorders due to use of alcohol
- Registration Number
- DRKS00023940
- Lead Sponsor
- Zentralinstitut für Seelische Gesundheit
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 10
Inclusion Criteria
Male and female subjects between 18 and 80 years old
- Existing alcohol dependence
- Indication for treatment with disulfiram
- Ability to give consent after detailed written explanation (Fully Informed Consent”)
- Informed consent must be in writing (Written Informed Consent”)
Exclusion Criteria
-Pregnancy
-Desire to have children
-lack of ability to consent
-Contraindications to treatment with disulfiram
Study & Design
- Study Type
- observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method This clinical study in a cross-over design aims to compare the compliance and probability of relapse of patients under the condition of a telemedical disulfiram consultation using the Zenalyser with the compliance and probability of relapse of these patients under the condition of participation in the face-to-face consultation. The aim is to compare the patients' adherence and compliance and the number of relapses in the telemedicine setting with their adherence, compliance and number of relapses in the face-to-face consultation.
- Secondary Outcome Measures
Name Time Method on-inferiority